223 related articles for article (PubMed ID: 19963138)
1. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies.
Wei BB; Xi B; Wang R; Bai JM; Chang JK; Zhang YY; Yoneda R; Su JT; Hua LX
Cancer Genet Cytogenet; 2010 Jan; 196(1):68-75. PubMed ID: 19963138
[TBL] [Abstract][Full Text] [Related]
2. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
[TBL] [Abstract][Full Text] [Related]
3. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
4. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
[TBL] [Abstract][Full Text] [Related]
5. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.
Gu D; Wang M; Wang M; Zhang Z; Chen J
Mutagenesis; 2009 Nov; 24(6):507-12. PubMed ID: 19762350
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage.
Argano C; Duro G; Corrao S; Di Chiara T; Nuzzo D; Colomba D; Scaglione R; Licata G
Blood Press; 2008; 17(4):220-6. PubMed ID: 18821144
[TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
8. Association of a TGF-β1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis.
Woo SU; Park KH; Woo OH; Yang DS; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Breast Cancer Res Treat; 2010 Nov; 124(2):481-5. PubMed ID: 20361250
[TBL] [Abstract][Full Text] [Related]
9. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
10. miR-196a2 C allele is a low-penetrant risk factor for cancer development.
Qiu LX; Wang Y; Xia ZG; Xi B; Mao C; Wang JL; Wang BY; Lv FF; Wu XH; Hu LQ
Cytokine; 2011 Dec; 56(3):589-92. PubMed ID: 21907588
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies.
He B; Zhang Y; Pan Y; Xu Y; Gu L; Chen L; Wang S
Mutagenesis; 2011 Sep; 26(5):637-42. PubMed ID: 21653279
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.
Kjaergaard AD; Ellervik C; Tybjaerg-Hansen A; Axelsson CK; Grønholdt ML; Grande P; Jensen GB; Nordestgaard BG
Circulation; 2007 Feb; 115(7):861-71. PubMed ID: 17309937
[TBL] [Abstract][Full Text] [Related]
13. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies.
Han S; Zhang HT; Wang Z; Xie Y; Tang R; Mao Y; Li Y
Eur J Hum Genet; 2006 Oct; 14(10):1136-44. PubMed ID: 16791138
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
15. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
Li H; Hao X; Zhang W; Wei Q; Chen K
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
[TBL] [Abstract][Full Text] [Related]
16. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
Le Marchand L; Haiman CA; van den Berg D; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
[TBL] [Abstract][Full Text] [Related]
17. SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.
Wang C; Tao W; Chen Q; Hu H; Wen XY; Han R
Prostate; 2010 Feb; 70(2):170-8. PubMed ID: 19760631
[TBL] [Abstract][Full Text] [Related]
18. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies.
Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z
Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678
[TBL] [Abstract][Full Text] [Related]
19. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
[TBL] [Abstract][Full Text] [Related]
20. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
Sparks R; Bigler J; Sibert JG; Potter JD; Yasui Y; Ulrich CM
Int J Epidemiol; 2004 Oct; 33(5):955-61. PubMed ID: 15020570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
